Anisperimus - CAS 170368-04-4

Anisperimus (LF 15-0195) is an immunosuppressant that enhances activation-induced T-cell death by promoting caspase-8 and caspase-10 activation at the DISC level, and prevents CNS autoimmunity by promoting the development of Foxp3-expressing regulatory CD4 T cells.

Endogenous Metabolite, Caspase

Metabolism, Proteases/Proteasome, Apoptosis

170368-04-4

0.981

C18H39N7O3

401.55

C(COC(NCCCCNCC[C@@H](C)N)=O)(NCCCCCCNC(=N)N)=O

-20°C

Ice Packs

Small Compound